{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T20:44:34Z","timestamp":1788295474568,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T00:00:00Z","timestamp":1661817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T00:00:00Z","timestamp":1661817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100014717","name":"National Outstanding Youth Science Fund Project of National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81925035"],"award-info":[{"award-number":["81925035"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Dysregulated mucosal immune responses and colonic fibrosis impose two formidable challenges for ulcerative colitis treatment. It indicates that monotherapy could not sufficiently deal with this complicated disease and combination therapy may provide a potential solution. A chitosan-modified poly(lactic-co-glycolic acid) nanoparticle (CS-PLGA NP) system was developed for co-delivering patchouli alcohol and simvastatin to the inflamed colonic epithelium to alleviate the symptoms of ulcerative colitis via remodeling immune microenvironment and anti-fibrosis, a so-called \u201ctwo-birds-one-stone\u201d nanotherapeutic strategy. The bioadhesive nanomedicine enhanced the intestinal epithelial cell uptake efficiency and improved the drug stability in the gastrointestinal tract. The nanomedicine effectively regulated the Akt\/MAPK\/NF-\u03baB pathway and reshaped the immune microenvironment through repolarizing M2\u03a6, promoting regulatory T cells and G-MDSC, suppressing neutrophil and inflammatory monocyte infiltration, as well as inhibiting dendritic cell maturation. Additionally, the\u00a0nanomedicine alleviated colonic fibrosis. Our work elucidates that the colon-targeted codelivery for combination therapy is promising for ulcerative colitis treatment and to address the unmet medical need.<\/jats:p>\n                <jats:p><jats:bold>Graphical Abstract<\/jats:bold><\/jats:p>","DOI":"10.1186\/s12951-022-01598-0","type":"journal-article","created":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T17:04:54Z","timestamp":1661879094000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["\u201cTwo-birds-one-stone\u201d colon-targeted nanomedicine treats ulcerative colitis via remodeling immune microenvironment and anti-fibrosis"],"prefix":"10.1186","volume":"20","author":[{"given":"Jiaxin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ante","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueping","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujuan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuefei","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuge","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhuo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,30]]},"reference":[{"key":"1598_CR1","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","volume":"389","author":"R Ungaro","year":"2017","unstructured":"Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF. Ulcerative colitis. Lancet. 2017;389:1756\u201370.","journal-title":"Lancet"},{"key":"1598_CR2","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","volume":"390","author":"SC Ng","year":"2017","unstructured":"Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, Panaccione R, Ghosh S, Wu JCY, Chan FKL, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390:2769\u201378.","journal-title":"Lancet"},{"key":"1598_CR3","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S2468-1253(16)30077-2","volume":"1","author":"GG Kaplan","year":"2016","unstructured":"Kaplan GG, Ng SC. Globalisation of inflammatory bowel disease: perspectives from the evolution of inflammatory bowel disease in the UK and China. Lancet Gastroenterol Hepatol. 2016;1:307\u201316.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1598_CR4","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S2468-1253(17)30004-3","volume":"2","author":"S Bopanna","year":"2017","unstructured":"Bopanna S, Ananthakrishnan AN, Kedia S, Yajnik V, Ahuja V. Risk of colorectal cancer in Asian patients with ulcerative colitis: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2017;2:269\u201376.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1598_CR5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.5217\/ir.2018.00126","volume":"17","author":"T Fukuda","year":"2019","unstructured":"Fukuda T, Naganuma M, Kanai T. Current new challenges in the management of ulcerative colitis. Intest Res. 2019;17:36\u201344.","journal-title":"Intest Res"},{"key":"1598_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrgastro.2015.186","volume":"13","author":"HS de Souza","year":"2016","unstructured":"de Souza HS, Fiocchi C. Immunopathogenesis of IBD: current state of the art. Nat Rev Gastroenterol Hepatol. 2016;13:13\u201327.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1598_CR7","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1038\/d41586-018-07277-1","volume":"563","author":"M Eisenstein","year":"2018","unstructured":"Eisenstein M. Gut reaction. Nature. 2018;563:S34\u20135.","journal-title":"Nature"},{"key":"1598_CR8","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.3389\/fimmu.2018.02764","volume":"9","author":"GR Jones","year":"2018","unstructured":"Jones GR, Bain CC, Fenton TM, Kelly A, Brown SL, Ivens AC, Travis MA, Cook PC, MacDonald AS. Dynamics of colon monocyte and macrophage activation during colitis. Front Immunol. 2018;9:2764.","journal-title":"Front Immunol"},{"key":"1598_CR9","doi-asserted-by":"publisher","first-page":"520","DOI":"10.7150\/ijbs.8879","volume":"10","author":"YC Liu","year":"2014","unstructured":"Liu YC, Zou XB, Chai YF, Yao YM. Macrophage polarization in inflammatory diseases. Int J Biol Sci. 2014;10:520\u20139.","journal-title":"Int J Biol Sci"},{"key":"1598_CR10","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12929-019-0539-4","volume":"26","author":"FC Yang","year":"2019","unstructured":"Yang FC, Chiu PY, Chen Y, Mak TW, Chen NJ. TREM-1-dependent M1 macrophage polarization restores intestinal epithelium damaged by DSS-induced colitis by activating IL-22-producing innate lymphoid cells. J Biomed Sci. 2019;26:46.","journal-title":"J Biomed Sci"},{"key":"1598_CR11","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.jconrel.2020.01.047","volume":"320","author":"J Zhang","year":"2020","unstructured":"Zhang J, Zhao Y, Hou T, Zeng H, Kalambhe D, Wang B, Shen X, Huang Y. Macrophage-based nanotherapeutic strategies in ulcerative colitis. J Control Release. 2020;320:363\u201380.","journal-title":"J Control Release"},{"key":"1598_CR12","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/imr.12974","volume":"302","author":"J Wang","year":"2021","unstructured":"Wang J, Lin S, Brown JM, van Wagoner D, Fiocchi C, Rieder F. Novel mechanisms and clinical trial endpoints in intestinal fibrosis. Immunol Rev. 2021;302:211\u201327.","journal-title":"Immunol Rev"},{"key":"1598_CR13","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1016\/j.apsb.2020.07.019","volume":"10","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Yang Y, Zhang J, Wang R, Cheng B, Kalambhe D, Wang Y, Gu Z, Chen D, Wang B, Huang Y. Lactoferrin-mediated macrophage targeting delivery and patchouli alcohol-based therapeutic strategy for inflammatory bowel diseases. Acta Pharm Sin B. 2020;10:1966\u201376.","journal-title":"Acta Pharm Sin B"},{"key":"1598_CR14","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1007\/s10620-007-0102-0","volume":"53","author":"M Ikeda","year":"2008","unstructured":"Ikeda M, Takeshima F, Isomoto H, Shikuwa S, Mizuta Y, Ozono Y, Kohno S. Simvastatin attenuates trinitrobenzene sulfonic acid-induced colitis, but not oxazalone-induced colitis. Dig Dis Sci. 2008;53:1869\u201375.","journal-title":"Dig Dis Sci"},{"key":"1598_CR15","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s10620-011-1879-4","volume":"57","author":"Y Abe","year":"2012","unstructured":"Abe Y, Murano M, Murano N, Morita E, Inoue T, Kawakami K, Ishida K, Kuramoto T, Kakimoto K, Okada T, et al. Simvastatin attenuates intestinal fibrosis independent of the anti-inflammatory effect by promoting fibroblast\/myofibroblast apoptosis in the regeneration\/healing process from TNBS-induced colitis. Dig Dis Sci. 2012;57:335\u201344.","journal-title":"Dig Dis Sci"},{"key":"1598_CR16","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ijcard.2018.06.061","volume":"270","author":"F Rizvi","year":"2018","unstructured":"Rizvi F, Siddiqui R, DeFranco A, Homar P, Emelyanova L, Holmuhamedov E, Ross G, Tajik AJ, Jahangir A. Simvastatin reduces TGF-\u03b21-induced SMAD2\/3-dependent human ventricular fibroblasts differentiation: role of protein phosphatase activation. Int J Cardiol. 2018;270:228\u201336.","journal-title":"Int J Cardiol"},{"key":"1598_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120461","volume":"600","author":"W Liu","year":"2021","unstructured":"Liu W, Dong Z, Liu K, Lu Y, Wu W, Qi J, Chen Z. Targeting strategies of oral nano-delivery systems for treating inflammatory bowel disease. Int J Pharm. 2021;600:120461.","journal-title":"Int J Pharm"},{"key":"1598_CR18","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.jconrel.2020.09.026","volume":"327","author":"R Ar\u00e9valo-P\u00e9rez","year":"2020","unstructured":"Ar\u00e9valo-P\u00e9rez R, Maderuelo C, Lanao JM. Recent advances in colon drug delivery systems. J Control Release. 2020;327:703\u201324.","journal-title":"J Control Release"},{"key":"1598_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2019.115613","volume":"230","author":"SQ Chen","year":"2020","unstructured":"Chen SQ, Song YQ, Wang C, Tao S, Yu FY, Lou HY, Hu FQ, Yuan H. Chitosan-modified lipid nanodrug delivery system for the targeted and responsive treatment of ulcerative colitis. Carbohydr Polym. 2020;230:115613.","journal-title":"Carbohydr Polym"},{"key":"1598_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.121382","volume":"612","author":"P Joyce","year":"2022","unstructured":"Joyce P, Wignall A, Peressin K, Wright L, Williams DB, Prestidge CA. Chitosan nanoparticles facilitate improved intestinal permeation and oral pharmacokinetics of the mast cell stabiliser cromoglycate. Int J Pharm. 2022;612:121382.","journal-title":"Int J Pharm"},{"key":"1598_CR21","doi-asserted-by":"publisher","first-page":"7697","DOI":"10.7150\/thno.45434","volume":"10","author":"X Cao","year":"2020","unstructured":"Cao X, Duan L, Hou H, Liu Y, Chen S, Zhang S, Liu Y, Wang C, Qi X, Liu N, et al. IGF-1C hydrogel improves the therapeutic effects of MSCs on colitis in mice through PGE(2)-mediated M2 macrophage polarization. Theranostics. 2020;10:7697\u2013709.","journal-title":"Theranostics"},{"key":"1598_CR22","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.jconrel.2020.10.052","volume":"329","author":"P Zhao","year":"2021","unstructured":"Zhao P, Zhang J, Wu A, Zhang M, Zhao Y, Tang Y, Wang B, Chen T, Li F, Zhao Q, Huang Y. Biomimetic codelivery overcomes osimertinib-resistant NSCLC and brain metastasis via macrophage-mediated innate immunity. J Control Release. 2021;329:1249\u201361.","journal-title":"J Control Release"},{"key":"1598_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2019.115126","volume":"223","author":"X Zhang","year":"2019","unstructured":"Zhang X, Ma Y, Ma L, Zu M, Song H, Xiao B. Oral administration of chondroitin sulfate-functionalized nanoparticles for colonic macrophage-targeted drug delivery. Carbohydr Polym. 2019;223:115126.","journal-title":"Carbohydr Polym"},{"key":"1598_CR24","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1084\/jem.20160462","volume":"214","author":"V Neudecker","year":"2017","unstructured":"Neudecker V, Haneklaus M, Jensen O, Khailova L, Masterson JC, Tye H, Biette K, Jedlicka P, Brodsky KS, Gerich ME, et al. Myeloid-derived miR-223 regulates intestinal inflammation via repression of the NLRP3 inflammasome. J Exp Med. 2017;214:1737\u201352.","journal-title":"J Exp Med"},{"key":"1598_CR25","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1053\/j.gastro.2016.09.047","volume":"152","author":"F Rieder","year":"2017","unstructured":"Rieder F, Fiocchi C, Rogler G. Mechanisms, management, and treatment of fibrosis in patients with inflammatory bowel diseases. Gastroenterology. 2017;152:340\u201350.","journal-title":"Gastroenterology"},{"key":"1598_CR26","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190103","volume":"217","author":"N Frangogiannis","year":"2020","unstructured":"Frangogiannis N. Transforming growth factor-\u03b2 in tissue fibrosis. J Exp Med. 2020;217: e20190103.","journal-title":"J Exp Med"},{"key":"1598_CR27","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/bjs.6577","volume":"96","author":"JP Burke","year":"2009","unstructured":"Burke JP, Watson RW, Murphy M, Docherty NG, Coffey JC, O\u2019Connell PR. Simvastatin impairs smad-3 phosphorylation and modulates transforming growth factor beta1-mediated activation of intestinal fibroblasts. Br J Surg. 2009;96:541\u201351.","journal-title":"Br J Surg"},{"key":"1598_CR28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12974-019-1474-8","volume":"16","author":"LT Guo","year":"2019","unstructured":"Guo LT, Wang SQ, Su J, Xu LX, Ji ZY, Zhang RY, Zhao QW, Ma ZQ, Deng XY, Ma SP. Baicalin ameliorates neuroinflammation-induced depressive-like behavior through inhibition of toll-like receptor 4 expression via the PI3K\/AKT\/FoxO1 pathway. J Neuroinflamm. 2019;16:95.","journal-title":"J Neuroinflamm"},{"key":"1598_CR29","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.biopha.2018.03.142","volume":"102","author":"FB Feng","year":"2018","unstructured":"Feng FB, Qiu HY. Effects of Artesunate on chondrocyte proliferation, apoptosis and autophagy through the PI3K\/AKT\/mTOR signaling pathway in rat models with rheumatoid arthritis. Biomed Pharmacother. 2018;102:1209\u201320.","journal-title":"Biomed Pharmacother"},{"key":"1598_CR30","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ctrv.2003.07.007","volume":"30","author":"JA Fresno Vara","year":"2004","unstructured":"Fresno Vara JA, Casado E, de Castro J, Cejas P, Belda-Iniesta C, Gonz\u00e1lez-Bar\u00f3n M. PI3K\/Akt signalling pathway and cancer. Cancer Treat Rev. 2004;30:193\u2013204.","journal-title":"Cancer Treat Rev"},{"key":"1598_CR31","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.phymed.2018.09.183","volume":"54","author":"MA Haque","year":"2019","unstructured":"Haque MA, Jantan I, Harikrishnan H, Ghazalee S. Standardized extract of Zingiber zerumbet suppresses LPS-induced pro-inflammatory responses through NF-\u03baB, MAPK and PI3K-Akt signaling pathways in U937 macrophages. Phytomedicine. 2019;54:195\u2013205.","journal-title":"Phytomedicine"},{"key":"1598_CR32","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1002\/jcp.29977","volume":"236","author":"YL Chen","year":"2021","unstructured":"Chen YL, Yan DY, Wu CY, Xuan JW, Jin CQ, Hu XL, Bao GD, Bian YJ, Hu ZC, Shen ZH, Ni WF. Maslinic acid prevents IL-1\u03b2-induced inflammatory response in osteoarthritis via PI3K\/AKT\/NF-\u03baB pathways. J Cell Physiol. 2021;236:1939\u201349.","journal-title":"J Cell Physiol"},{"key":"1598_CR33","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.apsb.2019.01.015","volume":"9","author":"F Zhou","year":"2019","unstructured":"Zhou F, Mei J, Han X, Li H, Yang S, Wang M, Chu L, Qiao H, Tang T. Kinsenoside attenuates osteoarthritis by repolarizing macrophages through inactivating NF-\u03baB\/MAPK signaling and protecting chondrocytes. Acta Pharm Sin B. 2019;9:973\u201385.","journal-title":"Acta Pharm Sin B"},{"key":"1598_CR34","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1158\/0008-5472.CAN-07-5278","volume":"68","author":"H Zhou","year":"2008","unstructured":"Zhou H, Ivanov VN, Lien YC, Davidson M, Hei TK. Mitochondrial function and nuclear factor-kappaB-mediated signaling in radiation-induced bystander effects. Cancer Res. 2008;68:2233\u201340.","journal-title":"Cancer Res"},{"key":"1598_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110471","volume":"129","author":"L Ju","year":"2020","unstructured":"Ju L, Hu P, Chen P, Xue X, Li Z, He F, Qiu Z, Cheng J, Huang F. Huoxuezhitong capsule ameliorates MIA-induced osteoarthritis of rats through suppressing PI3K\/Akt\/NF-\u03baB pathway. Biomed Pharmacother. 2020;129:110471.","journal-title":"Biomed Pharmacother"},{"key":"1598_CR36","doi-asserted-by":"publisher","first-page":"7458","DOI":"10.7150\/thno.38081","volume":"9","author":"W Han","year":"2019","unstructured":"Han W, Xie B, Li Y, Shi L, Wan J, Chen X, Wang H. Orally deliverable nanotherapeutics for the synergistic treatment of colitis-associated colorectal cancer. Theranostics. 2019;9:7458\u201373.","journal-title":"Theranostics"},{"key":"1598_CR37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.foodchem.2017.01.081","volume":"227","author":"Q Wang","year":"2017","unstructured":"Wang Q, Zhao Y, Guan L, Zhang Y, Dang Q, Dong P, Li J, Liang X. Preparation of astaxanthin-loaded DNA\/chitosan nanoparticles for improved cellular uptake and antioxidation capability. Food Chem. 2017;227:9\u201315.","journal-title":"Food Chem"},{"key":"1598_CR38","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/s41423-018-0032-0","volume":"16","author":"X Du","year":"2019","unstructured":"Du X, Wu Z, Xu Y, Liu Y, Liu W, Wang T, Li C, Zhang C, Yi F, Gao L, et al. Increased Tim-3 expression alleviates liver injury by regulating macrophage activation in MCD-induced NASH mice. Cell Mol Immunol. 2019;16:878\u201386.","journal-title":"Cell Mol Immunol"},{"key":"1598_CR39","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1136\/gut.2009.197822","volume":"59","author":"C Bauer","year":"2010","unstructured":"Bauer C, Duewell P, Mayer C, Lehr HA, Fitzgerald KA, Dauer M, Tschopp J, Endres S, Latz E, Schnurr M. Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome. Gut. 2010;59:1192\u20139.","journal-title":"Gut"},{"key":"1598_CR40","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1136\/gutjnl-2012-303207","volume":"63","author":"ME Johansson","year":"2014","unstructured":"Johansson ME, Gustafsson JK, Holm\u00e9n-Larsson J, Jabbar KS, Xia L, Xu H, Ghishan FK, Carvalho FA, Gewirtz AT, Sj\u00f6vall H, Hansson GC. Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis. Gut. 2014;63:281\u201391.","journal-title":"Gut"},{"key":"1598_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202103189","volume":"9","author":"NG Kotla","year":"2021","unstructured":"Kotla NG, Isa ILM, Rasala S, Demir S, Singh R, Baby BV, Swamy SK, Dockery P, Jala VR, Rochev Y, Pandit A. Modulation of gut barrier functions in ulcerative colitis by hyaluronic acid system. Adv Sci. 2021;9: e2103189.","journal-title":"Adv Sci"},{"key":"1598_CR42","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1053\/j.gastro.2017.05.056","volume":"153","author":"J Chang","year":"2017","unstructured":"Chang J, Leong RW, Wasinger VC, Ip M, Yang M, Phan TG. Impaired intestinal permeability contributes to ongoing bowel symptoms in patients with inflammatory bowel disease and mucosal healing. Gastroenterology. 2017;153:723\u201331.","journal-title":"Gastroenterology"},{"key":"1598_CR43","doi-asserted-by":"publisher","first-page":"8492","DOI":"10.1039\/D1FO01557E","volume":"12","author":"A Sharma","year":"2021","unstructured":"Sharma A, Tirpude NV, Kumari M, Padwad Y. Rutin prevents inflammation-associated colon damage via inhibiting the p38\/MAPKAPK2 and PI3K\/Akt\/GSK3\u03b2\/NF-\u03baB signalling axes and enhancing splenic Tregs in DSS-induced murine chronic colitis. Food Funct. 2021;12:8492\u2013506.","journal-title":"Food Funct"},{"key":"1598_CR44","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/apt.14526","volume":"47","author":"IO Gordon","year":"2018","unstructured":"Gordon IO, Agrawal N, Willis E, Goldblum JR, Lopez R, Allende D, Liu X, Patil DY, Yerian L, El-Khider F, et al. Fibrosis in ulcerative colitis is directly linked to severity and chronicity of mucosal inflammation. Aliment Pharmacol Ther. 2018;47:922\u201339.","journal-title":"Aliment Pharmacol Ther"},{"key":"1598_CR45","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abb4432","volume":"5","author":"BS Boland","year":"2020","unstructured":"Boland BS, He Z, Tsai MS, Olvera JG, Omilusik KD, Duong HG, Kim ES, Limary AE, Jin W, Milner JJ, et al. Heterogeneity and clonal relationships of adaptive immune cells in ulcerative colitis revealed by single-cell analyses. Sci Immunol. 2020;5: eabb4432.","journal-title":"Sci Immunol"},{"key":"1598_CR46","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1097\/MIB.0b013e318281f54e","volume":"19","author":"JC Brazil","year":"2013","unstructured":"Brazil JC, Louis NA, Parkos CA. The role of polymorphonuclear leukocyte trafficking in the perpetuation of inflammation during inflammatory bowel disease. Inflamm Bowel Dis. 2013;19:1556\u201365.","journal-title":"Inflamm Bowel Dis"},{"key":"1598_CR47","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/nm1758","volume":"14","author":"S Yamamoto","year":"2008","unstructured":"Yamamoto S, Shimizu S, Kiyonaka S, Takahashi N, Wajima T, Hara Y, Negoro T, Hiroi T, Kiuchi Y, Okada T, et al. TRPM2-mediated Ca2+ influx induces chemokine production in monocytes that aggravates inflammatory neutrophil infiltration. Nat Med. 2008;14:738\u201347.","journal-title":"Nat Med"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-022-01598-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-022-01598-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-022-01598-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T10:09:11Z","timestamp":1661940551000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-022-01598-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,30]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1598"],"URL":"https:\/\/doi.org\/10.1186\/s12951-022-01598-0","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,30]]},"assertion":[{"value":"9 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the animal experimental procedures were complied with the institutional ethical guidelines and approved by the Institutional Animal Care and Use Committee (IACUC), Shanghai Institute of Materia Medica, Chinese Academy of Sciences (IACUC No. SYXK2015-0027).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"389"}}